Dr Reddy’s receives DCGI’s approval to conduct clinical trial for Sputnik V vaccine in India

In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India.

 
– Stocks-Markets-Economic Times

• Share on Facebook
• Tweet it
• Pin it
• Share it
• Email